Evidence map›Paper›PMID 41517961›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Advancing global dementia research through equity and inclusion.

Natalia Vilor-Tejedor, Samuel Danso, Ricardo D'Oliveira Albanus, Kimberley Billingsley, Tavia Emily Evans, Liz Yuanxi Lee, Selena Wang, Jiyang Jiang, Hangfan Liu, Jermaine Ross and 1 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Advancing global dementia research through equity and inclusion.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Natalia Vilor-TejedorBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.ORCID https://orcid.org/0000-0003-4935-6721
Samuel DansoSchool of Computer Science and Engineering, Sunderland University, Sunderland, UK.
Ricardo D'Oliveira AlbanusDepartment of Neurology, MSC, St. Louis, Missouri, USA.
Kimberley BillingsleyCenter for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Tavia Emily EvansDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Liz Yuanxi LeeDepartment of Psychology, University of Cambridge, Cambridge, UK.
Selena WangDepartment of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Jiyang JiangCentre for Healthy Brain Ageing, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
Hangfan LiuHealth Sciences Facility III, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Jermaine RossAlleo Labs Corporation, San Francisco, California, USA.
Geetha ChillaBioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Matrix, Singapore.

Funding

Research Education ComponentP30AG072976 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI Yu-Chien Wu · 2021 to 2026
$24.1M
Genetic characterization of atypical parkinsonismZIANS003154 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI SCHOLZ, SONJA · 2016 to 2025
$15.4M
Genome wide SNP analysis in Parkinson's diseaseZ01AG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW B · 2006 to 2008
$2.6M
Deep-Learning Enhanced ASL MRI For Early AD AssessmentR01AG081693 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI Ze Wang · 2024 to 2026
$2.3M
MIDCAREER AWARD IN PATIENT ORIENTED RESEARCH ON AGINGK24AG000949 · NIA · YALE UNIVERSITY · PI INOUYE, SHARON K. · 1999 to 2009
$1.4M
AD Strategic Fund: Vascular Contributions to Cognitive Impairment and Dementia-Understanding Mechanisms of Dysfunction VCID-UMD-26-1514428Ajuntament de BarcelonaAlzheimer's Association Research postdoctoral fellowship 25AARF-1377279 (2025-2029)Alzheimer's Association Research postdoctoral fellowship WE.03-2024-07(2025-2027)Alzheimer's Disease Data InitiativeEuropean Union FEDER 23S06083-001European Union FSE+ PID2022-143106OA-I00Intramural NIH HHS Z01 AG000949Intramural NIH HHS ZIA NS003154Intramural Research Programs of the National Institute on Aging (NIA)la Caixa FoundationNational Institute of Neurological Disorders and Stroke (NINDS)National Institutes of Health (NIH), Department of Health and Human Services 1ZIANS003154National Institutes of Health (NIH), Department of Health and Human Services P30AG072976National Institutes of Health (NIH), Department of Health and Human Services R01AG081693National Institutes of Health (NIH), Department of Health and Human Services Z01-AG000949NIA NIH HHS K24 AG000949NIA NIH HHS P30 AG072976NIA NIH HHS R01 AG081693Spanish Ministry of Science and Innovation-State Research Agency, RYC2022-038136-I
6 · The paper itself

Abstract

Despite the global burden of dementia, research remains dominated by high-income, Western populations, limiting the generalizability and equity of findings. In this Perspective, we highlight the importance of diversity and inclusion in dementia research, not only in study participants but also in the researchers, study design, and funding priorities. We describe how the lack of representation creates knowledge gaps and delays progress in prevention, diagnosis, and treatment. We also present examples of initiatives that are working to change this, including the Alzheimer's Disease Data Initiative and the William H. Gates Sr. Fellowship program, which supports open science, international collaboration, and early-career researchers from underrepresented regions. These efforts demonstrate that diversity is not only an ethical goal, but a scientific need. More inclusive and global research could lead to discoveries that are more generalizable, more globally applicable, and better able to inform strategies to address dementia across all communities. HIGHLIGHTS: Prioritize representation in datasets across ethnicity, geography, sex/gender, and socio-economic status. Support early-career researchers from underrepresented regions with long-term funding and mentorship. Standardize and adapt tools (cognitive, clinical, genomic) across cultural and linguistic contexts. Promote open science through equitable, federated data sharing platforms, and embed community engagement from research design to dissemination. Value diversity as a driver of discovery, not as a confounder.

Indexed as

Biomedical ResearchDementiaDiversity, Equity, InclusionGlobal HealthHumansWorkforce Diversitycross‐cultural researchdiversity and inclusionopen scienceresearch equity

Identifiers

PMID41517961
PMCPMC12789878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.